Anti-PD-1 Neutralizing Antibody
Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy | Science Advances
Synergistic anti-tumor efficacy by combination therapy of a self-assembled nanogel vaccine with an immune checkpoint anti-PD-1 antibody - RSC Advances (RSC Publishing)
A Brief Introduction to PD-1 Antibodies and Immunotherapy | ProSci Incorporated
The FG Loop of PD-1 Serves as a “Hotspot” for Therapeutic Monoclonal Antibodies in Tumor Immune Checkpoint Therapy - ScienceDirect
Frontiers | Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma
Role of PD-1 during effector CD8 T cell differentiation | PNAS
In Vitro Potency Assays for Assessing the Function of anti-PD-1 Checkpoint Inhibitors
Anti-PD-1 Blocking Antibody Inhibits Human Melanoma Xenograft Growth in... | Download Scientific Diagram
PD-L1 Neutralizing Antibody
CS1003, a novel human and mouse cross-reactive PD-1 monoclonal antibody for cancer therapy | Acta Pharmacologica Sinica
PD-1 Specific 'Blocking' Antibodies That Deplete PD-1+ T Cells Present An Inconvenient Variable In Pre-clinical Immunotherapy Experiments | bioRxiv
Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma | Scientific Reports
Anti-mouse PD-1 (CD279) Antibody | Recombinant RMP1-14 | InvivoGen
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB/c mice reduce parasite load | Scientific Reports
Rational Design of Potent Peptide Inhibitors of the PD-1:PD-L1 Interaction for Cancer Immunotherapy | Journal of the American Chemical Society
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo | Nature Biotechnology
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging | PNAS
PD1 Antibody Selection Tool | Bio X Cell
PD-1 PD-L1 Blockade Bioassay | PD1 PDL1 | PD1 PDL1 Interactions
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer | NEJM
InVivoMAb anti-mouse CTLA-4 (CD152, Clone: 9D9) | Bio X Cell
